Atara Biotherapeutics, Inc. (ATRA) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $8.55 (+4.65%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 13, 2024 | Benjamin Burnett | Stifel Nicolaus | $10.00 | +17.0% |
| Aug 16, 2024 | Salim Syed | Mizuho Securities | $18.00 | +110.5% |
Top Analysts Covering ATRA
ATRA vs Sector & Market
| Metric | ATRA | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.50 | 2.25 | 2.42 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +63.1% | +16366.1% | +18.0% |
| P/E Ratio | 2.96 | 3.01 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $16M | $16M | $16M | 2 |
| 2027-12-31 | $51M | $51M | $51M | 3 |
| 2028-12-31 | $51M | $51M | $51M | 4 |
| 2029-12-31 | $91M | $91M | $91M | 3 |
| 2030-12-31 | $101M | $101M | $101M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.69 | $-0.69 | $-0.69 | 2 |
| 2027-12-31 | $-0.78 | $-0.78 | $-0.78 | 2 |
| 2028-12-31 | $-2.35 | $-0.30 | $1.86 | 4 |
| 2029-12-31 | $2.24 | $2.24 | $2.24 | 2 |
| 2030-12-31 | $2.45 | $2.45 | $2.45 | 2 |
Frequently Asked Questions
What is the analyst consensus for ATRA?
The consensus among 2 analysts covering Atara Biotherapeutics, Inc. (ATRA) is Buy with an average price target of $9.50.
What is the highest price target for ATRA?
The highest price target for ATRA is $18.00, set by Salim Syed at Mizuho Securities on 2024-08-16.
What is the lowest price target for ATRA?
The lowest price target for ATRA is $10.00, set by Benjamin Burnett at Stifel Nicolaus on 2024-11-13.
How many analysts cover ATRA?
2 analysts have issued ratings for Atara Biotherapeutics, Inc. in the past 12 months.
Is ATRA a buy or sell right now?
Based on 2 analyst ratings, ATRA has a consensus rating of Buy (2.50/5) with a +63.1% upside to the consensus target of $9.50.
What are the earnings estimates for ATRA?
Analysts estimate ATRA will report EPS of $-0.69 for the period ending 2026-12-31, with revenue estimated at $16M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.